Sign up to save your podcasts
Or
Share Shots-on-Goal Licensing Company Aims for Breakthroughs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Shots-on-Goal Licensing Company Aims for Breakthroughs
A very special breed of animals is helping biotech and pharma companies in the quest for new human therapeutics. CFO Kurt Gustafson joins Pathfinders in Biopharma to explain the technologies behind OmniAb’s business model.
View all episodes
By RBC Capital Markets
5
1212 ratings
A very special breed of animals is helping biotech and pharma companies in the quest for new human therapeutics. CFO Kurt Gustafson joins Pathfinders in Biopharma to explain the technologies behind OmniAb’s business model.
More shows like Pathfinders in Biopharma
View all
Motley Fool Money
3,230 Listeners
WSJ Your Money Briefing
1,719 Listeners
Exchanges
960 Listeners
Odd Lots
1,986 Listeners
WSJ Tech News Briefing
1,654 Listeners
The a16z Show
1,094 Listeners
The Long Run with Luke Timmerman
124 Listeners
The Readout Loud
334 Listeners
Wall Street Breakfast
1,046 Listeners
Thoughts on the Market
1,301 Listeners
The Journal.
6,086 Listeners
BioCentury This Week
35 Listeners
RBC's Markets in Motion
41 Listeners
Biotech Hangout
21 Listeners
Industries in Motion
10 Listeners
Powering Sustainable Ideas
0 Listeners
The Markets
78 Listeners
Strategic Alternatives
17 Listeners
The Top Line
16 Listeners
Macro Minutes
3 Listeners